Tissue Microarray Analysis of β-Catenin in Colorectal Cancer Shows Nuclear Phospho-β-catenin Is Associated with a Better Prognosis
Purpose : β-Catenin is involved in homotypic cell-cell adhesion and the wnt signaling pathway. Deregulation of β-catenin levels, caused in part by mutations of the adenomatous polyposis coli gene, is thought to play a role in the development of colorectal and other cancers. To further elucidate thei...
Gespeichert in:
Veröffentlicht in: | Clinical cancer research 2001-12, Vol.7 (12), p.4013-4020 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose : β-Catenin is involved in homotypic cell-cell adhesion and the wnt signaling pathway. Deregulation of β-catenin levels, caused in part by mutations of the adenomatous polyposis coli gene,
is thought to play a role in the development of colorectal and other cancers. To further elucidate their roles, the expression
pattern of β-catenin and phosphospecific β-catenin was correlated with clinical outcome in a series of patients with colorectal
cancer.
Experimental Design: Immunohistochemical analysis of a tissue microarray with 650 colorectal cancer specimens was performed to study the expression
and subcellular localization of β-catenin and phosphospecific β-catenin. These results were correlated with other clinicopathological
factors and with overall survival.
Results: The majority of cancers retained some degree of β-catenin membranous staining, whereas cytoplasmic or nuclear expression
was seen in 42.5% and 20.4% of specimens, respectively. Phospho-β-catenin showed nuclear staining in 9.5% of specimens, and
there was no apparent membranous or cytoplasmic staining. There was no significant association between β-catenin or phospho-β-catenin
and grade or stage. However, there was a positive correlation between β-catenin and phospho-β-catenin ( P = 0.039), with phospho-β-catenin representing a subset of nuclear β-catenin. Patients with nuclear expression of β-catenin
did not have an altered survival compared with those that did not ( P = 0.5611). Nuclear expression of phospho-β-catenin, however, was associated with an improved survival ( P = 0.0006). In multivariate analysis, only stage and phospho-β-catenin were independently predictive of overall survival ( P < 0.001 and P = 0.0034, respectively).
Conclusions: These findings support a role for β-catenin overexpression in colorectal tumorigenesis and provide initial evidence that
phospho-β-catenin may be a marker for improved overall survival independent of stage and grade. |
---|---|
ISSN: | 1078-0432 1557-3265 |